A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer
Clinical trial NCT04349280 · TERMINATED
Trial details
- NCT number
- NCT04349280
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2022-08-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.